Physician

Daniel Robert Whipple, M.D.

According to 2025 Medicare claims, Daniel Whipple, M.D. (NPI: 1164413431) practices ophthalmology in the Indianapolis-Carmel-Greenwood, IN market, with the plurality of this provider's patient population coming from Hendricks, IN. This provider's primary affiliated billing organization is MIDWEST EYE CONSULTANTS, PC (NPI: 1609621580; TIN: 351845786) and primary practice location at 46168-5557.

Whipple's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 668 traditional Medicare patients, billed 21,529 HCPCS/CPT codes, and received $1,618,617 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 2,126 prescription claims across 527 beneficiaries totaling $145,420 in drug costs, led by Restasis (Cyclosporine). DME data shows 63 claims. Open Payments data shows 31 records totaling $728. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $475,007 to $1,618,617. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $161,140 and ending at $145,420. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,457	6,537	$475,007
2016	1,363	7,446	$443,317
2017	1,069	7,385	$469,498
2018	1,002	7,221	$1,182,685
2019	965	6,549	$1,514,422
2020	996	7,150	$1,569,706
2021	816	6,288	$1,686,821
2022	787	6,383	$1,736,837
2023	763	8,088	$1,922,584
2024	668	21,529	$1,618,617

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	471	2,462	$161,140
2016	512	2,699	$180,046
2017	391	2,011	$153,573
2018	497	2,650	$149,230
2019	297	1,253	$97,653
2020	421	1,303	$118,821
2021	448	1,545	$117,588
2022	500	1,743	$141,770
2023	591	2,077	$178,385
2024	527	2,126	$145,420

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	373	436	$26,223
2016	333	386	$22,542
2017	357	412	$24,062
2018	298	357	$21,199
2019	283	326	$20,408
2020	217	242	$16,677
2021	194	219	$14,589
2022	122	140	$9,636
2023	74	82	$5,586
2024	57	63	$4,570

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	108	1,302	$653
67028	Injection of drug into eye	134	945	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	377	452	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	173	233	$60
92134	Imaging of retina	392	1,171	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	33	1,020	$21,555
Rhopressa	Netarsudil Mesylate	45	2,145	$21,018
Lumigan	Bimatoprost	42	2,439	$20,360
Prednisolone Acetate	Prednisolone Acetate	247	8,485	$14,552
Rocklatan	Netarsudil Mesylat/Latanoprost	22	643	$9,040

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	32	38	$2,402
V2200	Sphere, bifocal, plano to plus or minus 4.00d, per lens	N	13	13	$1,155
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	12	12	$1,013

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$728	Bausch & Lomb Americas Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Robert Whipple, M.D.?

Tedicare shows public-source Medicare data for Daniel Robert Whipple, M.D. (NPI 1164413431), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Robert Whipple, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Robert Whipple, M.D.?

Daniel Robert Whipple, M.D. is linked to MIDWEST EYE CONSULTANTS, PC (billing NPI 1609621580) in the available physician profile data.

Does Daniel Robert Whipple, M.D. have Open Payments data?

Daniel Robert Whipple, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.